Literature DB >> 12950028

Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.

Yajuan Zhao1, Kazuhiro Haginoya, Guilian Sun, Hongmei Dai, Akira Onuma, Kazuie Iinuma.   

Abstract

This study has examined the immunological localization of platelet-derived growth factor (PDGF)-A, PDGF-B, and PDGF receptor (PDGFR) alpha and beta to clarify their role in the progression of muscular dystrophy. Biopsied frozen muscles from patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and congenital muscular dystrophy (CMD) were analysed immunohistochemically using antibodies raised against PDGF-A, PDGF-B, and PDGFR alpha and beta. Muscles from two dystrophic mouse models (dy and mdx mice) were also immunostained with antibodies raised against PDGFR alpha and beta. In normal human control muscle, neuromuscular junctions and vessels were positively stained with antibodies against PDGF-A, PDGF-B, PDGFR alpha and PDGFR beta. In human dystrophic muscles, PDGF-A, PDGF-B, PDGFR alpha and PDGFR beta were strongly immunolocalized in regenerating muscle fibres and infiltrating macrophages. PDGFR alpha was also immunolocalized to the muscle fibre sarcolemma and necrotic fibres. The most significant finding in this study was a remarkable overexpression of PDGFR beta and, to a lesser extent, PDGFR alpha in the endomysium of DMD and CMD muscles. PDGFR was also overexpressed in the interstitium of muscles from dystrophic mice, particularly dy mice. Double immunolabelling revealed that activated interstitial fibroblasts were clearly positive for PDGFR alpha and beta. However, DMD and CMD muscles with advanced fibrosis showed very poor reactivity against PDGF and PDGFR. Those findings were confirmed by immunoblotting with PDGFR beta. These findings indicate that PDGF and its receptors are significantly involved in the active stage of tissue destruction and are associated with the initiation or promotion of muscle fibrosis. They also have roles in muscle fibre regeneration and signalling at neuromuscular junctions in both normal and diseased muscle. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950028     DOI: 10.1002/path.1414

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  17 in total

Review 1.  Meat Science and Muscle Biology Symposium: stem cell niche and postnatal muscle growth.

Authors:  P Bi; S Kuang
Journal:  J Anim Sci       Date:  2011-11-18       Impact factor: 3.159

Review 2.  Targeting fibrosis in Duchenne muscular dystrophy.

Authors:  Lan Zhou; Haiyan Lu
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

3.  [Inflammatory reactions in the wear particle induced and infectious periprosthetic membrane of loosened hip- and knee endoprostheses: pathogenetic relevance of differentially expressed genes cd9, cd11b, cd18, cd52 and pdgfrbeta].

Authors:  R Günther; L Morawietz; T Gehrke; L Frommelt; C Kaps; V Krenn
Journal:  Orthopade       Date:  2005-01       Impact factor: 1.087

4.  RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.

Authors:  Esther Fernández-Simón; Xavier Suárez-Calvet; Ana Carrasco-Rozas; Patricia Piñol-Jurado; Susana López-Fernández; Gemma Pons; Joan Josep Bech Serra; Carolina de la Torre; Noemí de Luna; Eduard Gallardo; Jordi Díaz-Manera
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-07       Impact factor: 12.910

5.  Imatinib attenuates skeletal muscle dystrophy in mdx mice.

Authors:  Ping Huang; Xinyu S Zhao; Matthew Fields; Richard M Ransohoff; Lan Zhou
Journal:  FASEB J       Date:  2009-03-16       Impact factor: 5.191

6.  Cardiomyopathy in the mouse model of Duchenne muscular dystrophy caused by disordered secretion of vascular endothelial growth factor.

Authors:  Dariusz Nowak; Hanna Kozlowska; Jerzy S Gielecki; Jan Rowinski; Anna Zurada; Krzysztof Goralczyk; Wladimir Bozilow
Journal:  Med Sci Monit       Date:  2011-11

7.  Regulation of DMD pathology by an ankyrin-encoded miRNA.

Authors:  Matthew S Alexander; Juan Carlos Casar; Norio Motohashi; Jennifer A Myers; Iris Eisenberg; Robert T Gonzalez; Elicia A Estrella; Peter B Kang; Genri Kawahara; Louis M Kunkel
Journal:  Skelet Muscle       Date:  2011-08-08       Impact factor: 4.912

8.  Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling.

Authors:  R Turk; E Sterrenburg; E J de Meijer; G-J B van Ommen; J T den Dunnen; P A C 't Hoen
Journal:  BMC Genomics       Date:  2005-07-13       Impact factor: 3.969

9.  Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report.

Authors:  Naif I AlJohani; Simon Carette; Jeffrey H Lipton
Journal:  J Med Case Rep       Date:  2015-09-16

10.  Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies.

Authors:  Alicia Alonso-Jiménez; Esther Fernández-Simón; Daniel Natera-de Benito; Carlos Ortez; Carme García; Elena Montiel; Izaskun Belmonte; Irene Pedrosa; Sonia Segovia; Patricia Piñol-Jurado; Ana Carrasco-Rozas; Xavier Suárez-Calvet; Cecilia Jimenez-Mallebrera; Andrés Nascimento; Jaume Llauger; Claudia Nuñez-Peralta; Paula Montesinos; Jorge Alonso-Pérez; Eduard Gallardo; Isabel Illa; Jordi Díaz-Manera
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.